Popular Articles

Yelp wanted
Google/Yelp: Google is dipping its hands further into the messy business of local search. The tech giant may splash out more than a half-billion dollars on Yelp, a website of local business reviews by customers. Google"s mobile ambitions make this a natural pairing. Yet Yelp’s untidy human element may fit awkwardly with Google’s clean algorithmic bent.

Gold imports treble in August at 21.8 tonnes
Gold imports witnessed nearly a three-fold jump during August at 21.8 tonnes as compared to the previous month on rising investment demand with the onset of festival and marriage season.

News of the day

Lawsuit filed against Sun Pharma's US arm
Sun Pharmaceutical Industries’ US subsidiary Caraco Pharmaceutical is facing more trouble in the US. A law firm, Izard Nobel LLP, has initiated a lawsuit seeking class action status against the company in the United States District Court for the Eastern District of Michigan on behalf of its investors.
Small Business

Merck acquires Bangalore Genei

German multinational drug major Merck KGaA has acquired Bangalore Genei (India) Pvt Ltd (BGIP), which specialises in new generation proteomic and genomic research technologies, the cutting-edge study of proteins and organisms. Merck, which acquired the company through its wholly-owned Indian subsidiary, Merck Specialities Private, did not disclose the deal’s size. Sensex ends up 35pts BGIP is a part of the Chennai-based speciality chemicals major, Sanmar Group. It has 100 employees and had generated total revenues of Rs 20.2 crore in 2008-09, according to a press release. By combining BGIP’s activities with Merck’s existing bioscience business, Merck will become one of the leading bioscience companies in India, the release added. “BGIP’s leadership in the Indian academic market, a segment with high growth potential, will ideally complement our existing customer base. BGIP’s product portfolio comprises a wide range of bioscience products, which are tailored to the needs of the domestic market in India.” said Christina Shasserre, global head of Merck’s bioscience business.


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):